Evidence map›Paper›PMID 40681482›Full record

SynthesisNature communications2025

Characterisation of between-cluster heterogeneity in malaria cluster randomised trials to inform future sample size calculations.

Joseph Biggs, Joseph D Challenger, Dominic Dee, Eldo Elobolobo, Carlos Chaccour, Francisco Saute, Sarah G Staedke, Sibo Vilakati, Jade Benjamin Chung, Michelle S Hsiang and 13 more

Abstract readMeta-Analysis
In one paragraph

Synthesis in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Joseph BiggsInternational Statistics and Epidemiology Group, Department of Infectious Disease Epidemiology and International Health, London School of Hygiene and Tropical Medicine (LSHTM), London, UK. joseph.biggs1@lshtm.ac.uk.ORCID http://orcid.org/0000-0001-7273-874X
Joseph D ChallengerMedical research Council (MRC) Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Faculty of Medicine, Imperial College London, London, UK.ORCID http://orcid.org/0000-0001-6029-1733
Dominic DeeMedical research Council (MRC) Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Faculty of Medicine, Imperial College London, London, UK.ORCID http://orcid.org/0000-0002-0087-3851
Eldo EloboloboCentro de Investigaçao em Saúde de Manhiça, Manhiça, Mozambique.ORCID http://orcid.org/0000-0002-8787-774X
Carlos ChaccourBarcelona Institute for Global Health (ISGlobal), Barcelona, Spain.ORCID http://orcid.org/0000-0001-9812-050X
Francisco SauteCentro de Investigaçao em Saúde de Manhiça, Manhiça, Mozambique.
Sarah G StaedkeDepartment of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, UK.
Sibo VilakatiNational Malaria Control Programme, Ministry of Health, Manzini, Eswatini.
Jade Benjamin ChungDepartment of Epidemiology and Population Health, Stanford University, Stanford, USA.ORCID http://orcid.org/0000-0003-3631-3132
Michelle S HsiangChan Zuckerberg Biohub, San Francisco, USA.
Edgard Diniba DabiraMedical Research Council (MRC) Unit The Gambia at the London School of Hygiene and Tropical Medicine (LSHTM), Disease Control & Elimination Theme, Fajara, The Gambia.
Annette ErhartMedical Research Council (MRC) Unit The Gambia at the London School of Hygiene and Tropical Medicine (LSHTM), Disease Control & Elimination Theme, Fajara, The Gambia.
Umberto D'AlessandroMedical Research Council (MRC) Unit The Gambia at the London School of Hygiene and Tropical Medicine (LSHTM), Disease Control & Elimination Theme, Fajara, The Gambia.
Rupam TripuraMahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Thomas J PetoMahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.ORCID http://orcid.org/0000-0003-3197-9891
Lorenz Von SeidleinMahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.ORCID http://orcid.org/0000-0002-0282-6469
Mavuto MukakaMahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Jacklin MoshaDepartment of Parasitology, National Institute for Medical Research, Mwanza, Tanzania.
Natacha ProtopopoffDepartment of Epidemiology and Public Health, Swiss Tropical & Public Health Institute, Basel, Switzerland.ORCID http://orcid.org/0000-0001-6698-4936
Manfred AccrombessiPopulation Services International (PSI), Malaria department, Cotonou, Benin.
Richard HayesInternational Statistics and Epidemiology Group, Department of Infectious Disease Epidemiology and International Health, London School of Hygiene and Tropical Medicine (LSHTM), London, UK.
Thomas S ChurcherMedical research Council (MRC) Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Faculty of Medicine, Imperial College London, London, UK.ORCID http://orcid.org/0000-0002-8442-0525
Jackie CookInternational Statistics and Epidemiology Group, Department of Infectious Disease Epidemiology and International Health, London School of Hygiene and Tropical Medicine (LSHTM), London, UK.

Funding

Gates Foundation INV-038132
6 · The paper itself

Abstract

Cluster randomised trials (CRTs) are important tools for evaluating the community-wide effect of malaria interventions. During the design stage, CRT sample sizes need to be inflated to account for the cluster heterogeneity in measured outcomes. The coefficient of variation (k), a measure of such heterogeneity, is typically used in malaria CRTs yet is often predicted without prior data. Underestimation of k decreases study power, thus increases the probability of generating null results. In this meta-analysis of cluster-summary data from 24 malaria CRTs, we calculate true prevalence and incidence k values using methods-of-moments and regression modelling approaches. Using random effects regression modelling, we investigate the impact of empirical k values on original trial power and explore factors associated with elevated k. Results show empirical estimates of k often exceed those used in sample size calculations, which reduces study power and effect size precision. Elevated k values are associated with incidence outcomes (compared to prevalence), lower endemicity settings, and uneven intervention coverage across clusters. Study findings can enhance the robustness of future malaria CRT sample size calculations by providing informed k estimates based on expected prevalence or incidence, in the absence of cluster-level data.

Indexed as

MalariaRandomized Controlled Trials as TopicCluster AnalysisHumansIncidencePrevalenceRegression AnalysisSample Size

Identifiers

PMID40681482
PMCPMC12274344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.